Workflow
*ST目药(600671) - 2020 Q1 - 季度财报
TMSPTMSP(SH:600671)2020-04-29 16:00

Financial Performance - Operating revenue fell by 26.40% to CNY 55,721,624.55 year-on-year[5] - Net profit attributable to shareholders was a loss of CNY 3,285,217.66, slightly improved from a loss of CNY 3,304,521.97 in the same period last year[5] - Basic and diluted earnings per share were both -CNY 0.0011, showing a slight improvement from -CNY 0.0154 in the previous year[5] - Total revenue for Q1 2020 was CNY 55,721,624.55, a decrease of 26.5% compared to CNY 75,708,330.55 in Q1 2019[36] - Net loss for Q1 2020 was CNY 557,941.39, compared to a net loss of CNY 1,005,525.92 in Q1 2019, showing an improvement of 44.3%[38] - The total comprehensive income for Q1 2020 was CNY 431,573.56, compared to CNY 132,534.73 in Q1 2019[42] Cash Flow - Cash flow from operating activities showed a significant decline, with a net cash outflow of CNY 314,260.47 compared to a positive cash flow of CNY 38,750,738.27 in the previous year[5] - Cash inflows from operating activities totaled CNY 61,568,802.22 in Q1 2020, down 44.9% from CNY 111,776,527.56 in Q1 2019[43] - The net cash flow from operating activities was negative CNY 314,260.47, a decline from a positive CNY 38,750,738.27 in Q1 2019[43] - Cash inflow from sales of goods and services was CNY 19,665,434.54, down 27.6% from CNY 27,149,366.51 in Q1 2019[46] - The ending cash and cash equivalents balance was CNY 19,889,610.15, down from CNY 64,813,183.49 at the end of Q1 2019[44] Assets and Liabilities - Total assets decreased by 2.06% to CNY 529,703,724.34 compared to the end of the previous year[5] - The total liabilities as of March 31, 2020, were CNY 390,564,760.43, compared to CNY 401,145,961.15 at the end of 2019, reflecting a decrease of about 2.0%[30] - The company's total assets as of Q1 2020 were CNY 317,107,780.62, slightly down from CNY 317,320,419.65 in the previous quarter[35] - The company's short-term borrowings increased from CNY 38,000,000.00 on December 31, 2019, to CNY 48,000,000.00 as of March 31, 2020, an increase of 26.3%[30] Shareholder Information - The total number of shareholders reached 16,649 by the end of the reporting period[8] - The largest shareholder, Changcheng Film and Television Culture Group, holds 30,181,813 shares, representing 24.78% of the total shares[10] - The second-largest shareholder, Qingdao Huilong Huaze Investment Co., Ltd., holds 26,799,460 shares, accounting for 22.01%[10] Investments and Projects - The company plans to invest CNY 14 million in the construction of the Xishuangbanna Great Wall Health Industry Park, holding a 9.33% stake[14] - A major engineering contract worth CNY 60 million was signed by the subsidiary Yinchuan Tianmu Mountain, exceeding 50% of the company's net assets[14] - The company acquired a new factory site for RMB 58 million, with a total construction area of 24,343.12 square meters, to mitigate the impact of the relocation[17] - A budget of RMB 75 million has been allocated for the GMP transformation of production lines at the new factory, with the first phase focusing on the main products[18] Legal and Financial Issues - As of March 31, 2020, RMB 24.6 million of funds occupied by the controlling shareholder and its affiliates remain unpaid[23] - The company has provided guarantees for loans totaling RMB 100 million to its controlling shareholder, which were not approved by the board and remain unresolved[21] - The company is actively pursuing the resolution of the RMB 24.6 million fund occupation and related legal issues with its controlling shareholder and affiliates[24] Other Financial Metrics - Cash and cash equivalents decreased by 22.60% from CNY 25,696,240.21 to CNY 19,889,610.15, primarily due to payments for various renovation projects[11] - Accounts receivable decreased by 41.89% from CNY 2,753,116.36 to CNY 1,599,834.84, mainly due to payments related to receivable notes[11] - Operating costs decreased by 20.44% from CNY 43,685,998.91 to CNY 34,758,053.59, corresponding to the decline in revenue[12] - Research and development expenses for Q1 2020 were CNY 226,796.00, compared to CNY 254,263.18 in Q1 2019, indicating a decrease of 10.8%[37]